Exploring GLP-1 telehealth options? Learn how Eden and Ro differ in the GLP-1 access and support services that they offer.
Ready to explore your GLP-1 treatment options?
Talk to a licensed provider and learn whether GLP-1 medications are appropriate for you.
GLP-1 receptor agonists, including medications such as semaglutide (Wegovy®) and tirzepatide (Zepbound®), are FDA-approved for specific medical conditions and are increasingly accessible through telehealth platforms. Eden and Ro are two companies that help individuals connect with licensed healthcare providers who may prescribe these medications when medically appropriate.
While both platforms support prescription access, they differ in how they approach ongoing support, provider interaction, and care personalization. This comparison outlines those differences to help you choose the path that best supports your personal goals and preferences.
Eden facilitates access to independent, licensed healthcare providers who assess each individual's health history, current symptoms, and overall health goals. These providers use clinical judgment to determine if GLP-1 therapy is appropriate and may offer customized treatment plans that go beyond medication alone. Depending on the provider's practice, users may be offered follow-up appointments to assess progress, adjust dosing, or refine behavioral strategies.
Unlike a standardized model, Eden allows providers discretion to tailor care to individual needs. Eden itself does not practice medicine, provide diagnoses, or manufacture drugs. Instead, it serves as a platform that connects users to healthcare professionals and licensed pharmacies.
Ro’s Body Program also includes medical evaluation, and eligible users may receive a prescription for a GLP-1 medication such as semaglutide. However, the structure of Ro’s program may be more protocol-based, with limited options for provider customization or follow-up care. This model may appeal to those who prefer a simpler, hands-off experience.
For many patients, lifestyle changes such as improved nutrition, physical activity, and habit formation may support their health goals when implemented under provider guidance. Eden’s platform gives providers the ability to offer integrated support tools, which may include resources for nutrition, physical activity, behavior change, and habit formation. These features help address the root causes of metabolic challenges, rather than focusing solely on prescription management.
Behavioral support may include guidance for meal planning, setting realistic goals, and managing emotional eating. Providers can incorporate these elements at their discretion, creating a more well-rounded and supportive treatment experience.
Ro’s Body Program includes educational articles and tracking tools within its member portal. These are typically self-guided and designed to support independent behavior change. While useful, this approach may not provide the same level of individualized or clinician-guided support as Eden’s more flexible model.
Looking for care designed around your needs?
Eden helps you connect with licensed providers who can guide your next steps with a personalized approach.
Every person’s experience with GLP-1 medications is unique, and treatment needs can change over time. Eden’s platform enables providers to tailor care plans according to individual responses, side effects, or emerging health goals. This flexibility is especially valuable for people who experience medication-related side effects, require slower dose titration, or have complex health histories.
Providers using Eden’s platform may recommend tailored timelines for follow-up or make real-time adjustments to dosage. This flexibility may help providers address patient concerns in a timely manner, which some users may find beneficial.
In contrast, Ro’s program is designed for convenience and uniformity. While this streamlined experience can be beneficial for users who value simplicity, it may not be as responsive to individual differences or changes in health status.
Transparent pricing is important when starting a new treatment. Eden offers upfront pricing for the initial consultation, as well as access to tools provided through the platform. If a provider prescribes medication, Eden connects users with independent state-licensed pharmacies that fulfill prescriptions. Final medication costs can vary based on insurance coverage, medication availability, and pharmacy policies.
Eden does not sell medications or set drug prices. Instead, it ensures users are connected to qualified professionals and reliable pharmacy partners who manage the fulfillment process in compliance with applicable regulations.
Ro operates on a subscription model that bundles together provider evaluation, educational tools, and digital support. While some users may find this structure convenient, pricing transparency and pharmacy access may vary depending on the specific plan and provider participation.
Safety is a key concern when using any prescription medication. GLP-1 receptor agonists have been shown in clinical studies to be effective in supporting weight loss and improving metabolic health when used appropriately. In a controlled clinical setting (STEP 1 trial), participants with obesity who were prescribed semaglutide in combination with a structured lifestyle program lost an average of 14.9% of their body weight over 68 weeks. These results reflect the outcomes of a clinical trial and may not be representative of real-world experience.*
However, individual results vary, and GLP-1s are not suitable for everyone. Common side effects include nausea, constipation, and injection-site reactions. In rare cases, more serious complications may occur.
Eden prioritizes safety by connecting users with independent, licensed providers who assess contraindications, monitor for side effects, and adjust treatment when clinically appropriate Eden does not guarantee prescriptions or promote any specific outcome. All treatment decisions are made solely by the provider.
Ro also requires users to complete a medical intake and undergo eligibility screening. However, because the program may include fewer touchpoints or opportunities for follow-up, some users may prefer a model that offers closer clinical oversight.
*In the STEP 1 trial, participants received semaglutide 2.4 mg once weekly via subcutaneous injection, the FDA-approved formulation later marketed under the brand name Wegovy® for chronic weight management in adults with obesity or overweight and at least one weight-related condition.
Want a care experience built around your goals?
Take the first step with Eden and connect with a provider who understands your needs.
Ro’s Body Program offers convenience and medication access. But for those seeking a more individualized, medically supervised approach with built-in support tools, Eden’s platform may offer a more personalized care model through providers who may incorporate ongoing support and lifestyle planning.
When choosing between programs, consider what’s most important to you—quick access to prescriptions or a more comprehensive, provider-led approach to your health goals.
Considering GLP-1 treatment?
Connect with a licensed medical provider who can evaluate your eligibility and discuss the best treatment options for your needs.
Start Your Personalized Evaluation →
This article is for informational purposes only and does not constitute medical advice. Eden does not guarantee prescriptions or specific outcomes. All treatment decisions are made by independent licensed medical providers based on clinical judgment. Always consult a healthcare professional before starting or stopping any medication.
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
